Healthy Living/WellnessFDA Greenlights Allergan Drug Vraylar For Schizophrenia And Bipolar Disorder After enduring 9 weeks of clinical trials, Vraylar was deemed successful enough in treating symptoms of schizophrenia and manic bipolar episodes in adults to earn FDA approval for use.by Julienne Roman
Healthy Living/WellnessPregnancy Timing: Siblings Born Within 2 Years Of Each Other More Likely To Develop Autismby Julienne Roman
Healthy Living/WellnessPublic Schools To Stock Drug Antidote Naloxone In Response To Heroin Epidemicby Katherine Derla
Healthy Living/WellnessAdvaxis’ Experimental Cancer Immunotherapy Axalimogene Filolisbac Boosts Survival Rates In Cervical Cancer Patientsby Julienne Roman
Healthy Living/WellnessMedical Experts Speak Out About GOP Vaccine Claims In Recent Debateby Rina Marie Doctor
Healthy Living/WellnessPassive Smoking Increases Diabetes Risks By 22 Percent: How To Reduce Exposure To Secondhand Smokeby Katherine Derla
Healthy Living/WellnessUniversal Health Services Shelling Out $350M To Buy Addiction Treatment Company Foundations Recovery Networkby Katherine Derla
Healthy Living/WellnessWoman Suffering From Severe Headache Has Tapeworm Eggs in Her Brainby Katherine Derla
Healthy Living/WellnessU.S. Health Officials: No More Ebola Screening For Travelers From Liberiaby Rina Marie Doctor
Healthy Living/WellnessMold At Pittsburgh Hospital May Have Contributed To Death Of Two Patientsby Katherine Derla